IMF Virtual Myeloma Community Workshop (MCW): “What’s the ‘Right’ Answer? – Controversies in Myeloma” (https://www.myeloma.org/videos/imf-mcw-whats-the-right-answer)
This IMF Virtual Myeloma Community Workshop will offer an interactive afternoon of expert debates on key issues in myeloma care. IMF Vice President of Patient Support Robin Tuohy will provide an overview of IMF resources. Then, key myeloma experts will present and discuss opposing perspectives on whether to treat high-risk smoldering myeloma, the role of MRD in guiding transplant and maintenance decisions, and the use of CAR T-cell therapy at first relapse. At the end of the program, there will be a Q&A, and attendees will have ample time to ask questions.
Connect with myeloma specialists and experts through a panel Q&A, where panelists will address questions specific to the topics covered.
Workshop Sponsors:
With Support From: Abbvie, Amgen, GSK, Johnson & Johnson, Karyopharm, Pfizer, Sanofi, and Takeda Oncology
(The IMF is not responsible for content provided by the links below and you may be subject to the Privacy Policy and Terms & Conditions of the destination site(s).)
.png)
